Skip to main content
TipRanks
Go Ultimate75% OFF

Daewoong Pharmaceutical Co., Ltd. (069620) Stock Statistics & Valuation Metrics

Total Valuation

Daewoong Pharmaceutical Co., Ltd. has a market cap or net worth of KRW 1.16T. The enterprise value is KRW 2.15T.

Market Cap
KRW 1.16T
Enterprise Value
KRW 2.15T

Share Statistics

Daewoong Pharmaceutical Co., Ltd. has 11,586,575 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
11,586,575
Owned by Insiders
―
Owned by Institutions
5.09%

Financial Efficiency

Daewoong Pharmaceutical Co., Ltd.’s return on equity (ROE) is 0.19 and return on invested capital (ROIC) is 9.52%.

Return on Equity (ROE)
0.19
Return on Assets (ROA)
0.08
Return on Invested Capital (ROIC)
9.52%
Return on Capital Employed (ROCE)
0.11
Revenue Per Employee
875.63M
Profits Per Employee
109.17M
Employee Count
1,794
Asset Turnover
0.66
Inventory Turnover
2.44

Valuation Ratios

The current PE Ratio of Daewoong Pharmaceutical Co., Ltd. is 6.25. Daewoong Pharmaceutical Co., Ltd.’s PEG ratio is 0.06.

PE Ratio
6.25
PS Ratio
0.69
PB Ratio
1.09
Price to FCF
-9.68
Price to Operating Cash Flow
8.68
PEG Ratio
0.06

Income Statement

In the last 12 months, Daewoong Pharmaceutical Co., Ltd. had revenue of 1.57T and earned 195.86B in profits. Earnings per share was 17021.00.

Revenue
1.57T
Gross Profit
812.85B
Operating Income
195.51B
Pretax Income
191.83B
Net Income
195.86B
EBITDA
245.78B
Earnings Per Share (EPS)
17021.00

Cash Flow

In the last 12 months, operating cash flow was 134.37B and capital expenditures -254.07B, giving a free cash flow of -119.69B billion.

Operating Cash Flow
134.37B
Free Cash Flow
-119.69B
Free Cash Flow per Share
-10329.90

Dividends & Yields

Daewoong Pharmaceutical Co., Ltd. pays an annual dividend of ―, resulting in a dividend yield of 0.60%

Dividend Per Share
―
Dividend Yield
0.60%
Payout Ratio
N/A
Free Cash Flow Yield
-10.39%
Earnings Yield
15.82%

Stock Price Statistics

Beta
0.08
52-Week Price Change
-42.06%
50-Day Moving Average
106516.00
200-Day Moving Average
132212.50
Relative Strength Index (RSI)
42.05
Average Volume (3m)
20.25K

Important Dates

Daewoong Pharmaceutical Co., Ltd. upcoming earnings date is Mar 23, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 13, 2026
Next Earnings Date
Mar 23, 2027
Ex-Dividend Date
―

Financial Position

Daewoong Pharmaceutical Co., Ltd. as a current ratio of 1.24, with Debt / Equity ratio of 82.44%

Current Ratio
1.24
Quick Ratio
0.72
Debt to Market Cap
0.41
Net Debt to EBITDA
2.69
Interest Coverage Ratio
15.67

Taxes

In the past 12 months, Daewoong Pharmaceutical Co., Ltd. has paid -1.08B in taxes.

Income Tax
-1.08B
Effective Tax Rate
-0.01

Enterprise Valuation

Daewoong Pharmaceutical Co., Ltd. EV to EBITDA ratio is 7.02, with an EV/FCF ratio of -16.36.

EV to Sales
1.16
EV to EBITDA
7.02
EV to Free Cash Flow
-16.36
EV to Operating Cash Flow
14.57

Balance Sheet

Daewoong Pharmaceutical Co., Ltd. has KRW 150.90B in cash and marketable securities with KRW 952.75B in debt, giving a net cash position of -KRW 801.85B billion.

Cash & Marketable Securities
KRW 150.90B
Total Debt
KRW 952.75B
Net Cash
-KRW 801.85B
Net Cash Per Share
-KRW 69.21K
Tangible Book Value Per Share
KRW 102.85K

Margins

Gross margin is 51.88%, with operating margin of 12.18%, and net profit margin of 10.91%.

Gross Margin
51.88%
Operating Margin
12.18%
Pretax Margin
10.00%
Net Profit Margin
10.91%
EBITDA Margin
16.57%
EBIT Margin
12.10%

Analyst Forecast

The average price target for Daewoong Pharmaceutical Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
9.16%
EPS Growth Forecast
96.95%

Scores

Smart Score
―
AI Score
62